Company intelligence / Profile preview
Chia Tai Qingjiang
- Ownership
- Private
- Employees
- ~1200
- Development stage
- Other
Overview
Chia Tai Qingjiang is a prominent Chinese pharmaceutical company and a key subsidiary of Sino Biopharmaceutical. The company specializes in orthopedics, cardiovascular health, and pain management, and is one of the leading manufacturers of glucosamine sulfate (brand name Saile) in the Chinese market.
- Therapeutic areas
- EndocrinologyCardiovascularRheumatologyNeurology
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Chia Tai Qingjiang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chia Tai Qingjiang.